Overview

A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers

Status:
NOT_YET_RECRUITING

Trial end date:
2026-08-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to healthy adult volunteers.

Phase:

PHASE1

Details

Lead Sponsor:

Bugworks Research Inc.

Collaborator:

Nucleus Network Ltd